ASTEX PHARMACEUTICALS Trademark

Trademark Overview


On Friday, July 18, 2025, a trademark application was filed for ASTEX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the ASTEX PHARMACEUTICALS trademark a serial number of 79432260. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 11, 2025. This trademark is owned by Astex Therapeutics Limited. The ASTEX PHARMACEUTICALS trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing health care information via telephone and the internet; providing information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals.

Drug discovery and development services; biotechnology research; scientific analysis; providing scientific information in the field of pharmaceuticals and clinical trials; pharmaceutical research services.

Computer software for use in relation to drug discovery; computer software for use in relation to biotechnology research; computer software for use in relation to scientific analysis; computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in drug discovery, biotechnology research and scientific analysis; computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in drug discovery, biotechnology research and scientific analysis; computer programs and algorithms for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, natural language human-machine interfaces and predictive assistance technologies; recorded computer programs using artificial intelligence, machine ...
astex pharmaceuticals

General Information


Serial Number79432260
Word MarkASTEX PHARMACEUTICALS
Filing DateFriday, July 18, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, September 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding health care information via telephone and the internet; providing information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals.
Goods and ServicesDrug discovery and development services; biotechnology research; scientific analysis; providing scientific information in the field of pharmaceuticals and clinical trials; pharmaceutical research services.
Goods and ServicesComputer software for use in relation to drug discovery; computer software for use in relation to biotechnology research; computer software for use in relation to scientific analysis; computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in drug discovery, biotechnology research and scientific analysis; computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in drug discovery, biotechnology research and scientific analysis; computer programs and algorithms for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, natural language human-machine interfaces and predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of drug discovery, biotechnology research and scientific analysis.

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, September 11, 2025
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 11, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 11, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstex Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, September 11, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, September 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 15, 2025APPLICATION FILING RECEIPT MAILED
Thursday, November 20, 2025NEW REPRESENTATIVE AT IB RECEIVED